Login

Cyclo Therapeutics, Inc. 3 SEC Filings

Filed On Filing
28 Dec 2023 Form 3: Cross Shawn, Director

Holds 0 shares of Common Stock

21 Aug 2023 Form 3: Wong Vivien, Director

Holds 0 shares of Common Stock

08 May 2023 Form 3: Rafael Holdings, Inc., 10% owner

Holds 2,514,970 shares of Common Stock, par value $0.0001 per share

08 May 2023 Form 3: Conkling William, Director

Holds 0 shares of Common Stock

28 Sep 2021 Form 3: Kjems Lise Lund, Chief Medical Officer

No securities owned

24 Sep 2020 Form 3: Lisjak Michael Eric, Chief Regulatory Officer

Holds 240,000 shares of Common Stock

31 Aug 2020 Form 3: Armistice CAPITAL, Llc, 10% owner and 2 others

Holds 19,027,050 shares of Common Stock, par value $.0001 per share

21 Jun 2019 Form 3: Fine Joshua M, Chief Financial Officer

Holds 598,000 shares of Common Stock

09 Jul 2018 Form 3: Hrynkow Sharon Hemond, SVP for Medical Affairs

Holds 235,000 shares of Common Stock

10 Apr 2018 Form 3: Toig Randall M., Director

No securities owned

23 Oct 2017 Form 3: NOVIT, L.p., 10% owner and 2 others

Holds 6,471,248 shares of Common Stock

10 Jun 2016 Form 3: Shanahan William S, Director

Holds 425,900 shares of Common Stock

09 Nov 2015 Form 3: Farnan Joseph J Jr, Director

Holds 650,000 shares of Common Stock

22 Jul 2015 Form 3: NOVIT, L.p., 10% owner and 2 others

Holds 5,900,000 shares of Common Stock

21 Apr 2014 Form 3: Ostronic Francis Patrick, Director

Holds 15,000 shares of Common Stock

21 Feb 2014 Form 3: Fine N Scott, Director

No securities owned

21 Feb 2014 Form 3: Sieger Markus, Director

No securities owned

28 Oct 2010 Form 3: Strattan Ce Rick, Director

No securities owned

18 Aug 2010 Form 3: Tate Jeffrey, Director

No securities owned

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support